Six different procedures for radioiodination of mouse epidermal growth factor (EGF) all resufted in a heterogeneous 125I.lled EGF preparation, as analyzed by reversed-phase HPLC. EGF preparations that had been iodinated with Chioramine T, lodogen ', or Iodo-beads were found mainly to consist of oxidized '25I4giIed EGF moieties. In contrast, the heterogeneous 1l-labeled EGF preparations obtained by using iodine monochlonde, Protag-125, or lactoperoxidase-glucose oxidase-coupled beads (Enzymobeads") contained insignificantamounts of oxidized EGF entities. Ugand equivalence analysis (LEA) of distinct HPLC column fractions, obtained after preparative separation of Chloramine T-125l-labeled EGF, showed that the receptor-binding affinityof the tracer in all subfractions was less than the affinity of unlabeled EGF.
ilgand equWalence analysis
Various methods have been described for radioiodination of epidermal growth factor (EGF) (1) (2) (3) (4) (5) (6) (7) (8) 
Human
placental membranes were obtained as described earlier (9) . As shown in the HPLC elution profiles (Figure 1 ), all six iodination methods used resulted in a heterogeneous 'I-1abe1ed EGF preparation.
However, EGF that was iodinated
by using Chlorainine T, Iodogen, or lodo-beads (Figure la-c) showed the predominant HPLC peaks at shorter retention times than for unlabeled EGF. For EGF labeled with use of Enzymebeads,  or iodine monochioride, the predominant peaks were shifted to longer retention times (Figure id-f To study the effect of the nonradioactive reagents per se on the chromatographic properties of EGF, we performed the reactions under the conditions described for iodination but with no radioiodide (Figure 2) . The HPLC apparatus in this case was equipped with a fluorescence detector. Treating EGF with the Chioramine T, lodogen, or Iodo-beads reagents resulted in shorter retention times (Figure 2a-c) . In contrast, treating EGF with the Enzymobeads or Protag-l25 reagents (Figure 2d, e) did not affect the elution position of the protein, except for a slight increase of the first peak in the elution profile of Protag-treated EGF. Treatment of EGF with nonradioactive IC1 yielded several fluorescent peaks, one with the retention time of native EGF and others with longer retention times (Figure 2f) , probably from the incorporation of nonradloactive iodine from the IC1 molecule into EGF. 
HPLC, we chromatographed preparatively Chioramine T-and Enzymobeads-'251-labeled
EGF. HPLC column fractions (1 mL) were collected and counted for radioactivity. Four peaks (Figure 4) were analyzed separately. Each peak was rechromatographed on HPLC (see inserts of Figures 5 and 6 ) and analyzed by LEA, as described in Materials and Methods. LEA should result in a horizontal plot when the affinity of the 'WI-labeled EGF for the receptor remains unchanged by iodination. As the sloping lines in Figure 5 show, all four i251 labeled EGF fractions obtained after chromatography of Chloramine T-1I-labe1ed EGF had less affinity for the placental EGF receptor than did the unlabeled EGF. As discussed previously, the specific radioactivity of such uganda cannot be determined with LEA (9).
The binding behavior of the pooled Enzymobeads-'Ilabeled EGF preparations was also investigated by LEA. Three fractions (E2, E3, and E4) obtained after HPLC contained 'I-labeled EGF that was equivalent to unlabeled EGF in receptor binding, as can be concluded from the horizontal plots ( Figure 6b-d) ; therefore, these fractions could be used for accurate determinations of specific radioactivity. In contrast, LEA of the El tracer resulted in a nonhorizontal plot, indicating nonequivalence ( Figure 6a ). This El tracer could have been generated by iodination of already oxidized EGF entities present in the unlabeled EGF preparation (Figure 2a, dashed line) . The overall nonchromatographed 1I-labeled EGF preparation (E0) showed ligand equivalence (specific radioactivity 570 ± 80 kCi/mol, mean ± SD, n = 7), from which it appears that no interference is encountered from the presence of the small amount of the nonequivalent El tracer. Another mild radioiodination procedure such as that with IC1 also yielded a tracer with overall ligand equivalence (Figure 3, insert) . Oxidation of this ICl-1I-labeled EGF preparation by hydrogen peroxide introduced nonequivalence in binding behavior between labeled and unlabeled EGF (Figure 3 , insert). The specific radioactivities of the fractions E2, E3, and E4 varied widely (Figure 6) Human placental membranes were equilIbrated with Increasing amounts of l30 EGF (saturationanalyals)or with one concentration of l26 labeled EOF and Increasing conreotations of unlabeled EGF (competition analysis)Ina total volume of 140 g4.at 20 C. Specific binding was calculated as the difference between total bIndIngand nonspecific bindIng, assessed In parallelincitiatlone in the presenceof 250-fold excess ofunlabeledEGF.The nonspecificbinding ranged from 0.8%to 1.8% of the total radioactivityadded for all Wabeled EGF preparations elided. Separation of receptor-bound and free ilgand was pedormed by ad.omp&n of receptor-boundEGFto HAP. n number of receptors; Kd -dIssociationconstant.
sulted in similar numbers of receptors (n) and similar apparent dissociation constants (Kd).
DIscussion
We have previously demonstrated that radioiodination of mouse EGF by using Chioramine T, lodogen, or lodo-beads results in an 'I-labeled EGF preparation with a decreased receptor binding affinity as compared with unlabeled EGF (9) Despite iodination or oxidation, all the '25I-labeled EGF preparations examined were able to bind by >95% to the receptors in human placental membrane preparations. Moreover, treatment of EGF in the presence of nonradioactive NaJ with IC! (iodination) or with Chloramine T (iodination and oxidation) did not affect its biological activity significantly. The latter was established in a serum-free proliferation assay with normal rat kidney cells (20) . Similar observations were made by Matrisian et al. (8) , who showed that EGF radioiodinated with Chloramine T retained its biological activity.
The present study revealed that HPLC purification of 1251-labeled EGF, prepared by harsh oxidative iodination methods, did not result in an EGF tracer with better binding characteristics than the overall Ilabeled EGF preparation. Moreover, HPLC purification of lmIlabeled EGF prepared by mild iodination methods (Enzymobeads, Id, and Protag-125) is superfluous, because the overall heterogeneous 'I-labeled EGF preparations showed ligand equivalence. HPLC purification, however, can yield tracers of very high specific radioactivity (>3000 kCi/mol) and ligand equivalence through the use of these mild radioiodination methods.
